HSCS
HeartSciences Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-07-23
Figures on this page computed 2026-11-08 12:40 UTC
Last close
3.10USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2026, filed 2026-07-23
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
- computed
- 10-K for 2026, filed 2026-07-23
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
-211666.5%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
-172036.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
- 10-K for 2026, filed 2026-07-23
- 10-K for 2026, filed 2026-07-23
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
- 10-K for 2026, filed 2026-07-23
- 10-Q for 2026, filed 2026-09-14
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.05 against 0.52 on the market's range.
- Growth-29.9%23 of 100, below its sector
- Returns on capital-4044.0%1 of 100, below its sector
- Margins59.1%19 of 100, below its sector
- Price32.3x1 of 100, below its sector
- Safety0.535 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 2 of 3- Profit on each unit of sales-211,666%-1,018%Behind
Higher is better here.
- Return on the capital it usesn/an/an/a
Higher is better here.
- Sales growth over five years-30.0%11.4%Behind
Higher is better here.
- Debt against equityn/a1.11n/a
Lower is better here.
- Gross margin59.1%45.3%Ahead
Higher is better here.
- Price against earningsn/an/an/a
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Sintx Technologies, Inc., HSCS is behind on 2 of 3 measures.
Against Sintx Technologies, Inc., HSCS is behind on 2 of 3 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2026, filed 2026-07-23
Profit on each unit of sales-211666.5%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
Return on the capital it usesn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
Sales growth over five years-29.9%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
Debt against equityn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
Gross margin59.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD
Price against earningsn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001437749-26-024337
- Reported in
- USD